Skip to main content
. Author manuscript; available in PMC: 2009 May 8.
Published in final edited form as: J Immunol. 2007 Mar 15;178(6):3688–3694. doi: 10.4049/jimmunol.178.6.3688

Table I.

Clinical parameters of TB patients

Patient Gendera Age (years) TST Smear Culture Anti-TB Treatmentb (wk)
01 F 58 NT + 1.29
02 M 49 NT + 2.90
03 M 40 + + 2.43
04 F 22 + + 2.86
05 M 19 + + 0.71
06 M 37 + + 1.86
07 F 37 + + 2.57
08 M 53 + + 1.57
09 M 40 + + 0.00
10 F 31 + + 2.14
11 F 40 + + 0.71
12 M 36 + + 0.00
13 F 33 + + 1.00
14 F 36 + + 2.43
15 F 73 NT + 1.14
16 F 76 + + 0.00
17 F 31 + + 1.43
18 M 19 NT + 0.00
19 M 37 + + 2.00
20 M 30 + + 0.00
21 F 38 + 0.86
22 F 51 + 1.00
23 M 47 + 0.00
24 M 66 + 0.00
25 F 27 NT 0.00
26 M 48 + 0.86
27 F 23 + 0.57
28 M 77 NT 0.43
29 F 61 + 0.00
30 F 38 + 0.00
a

Female; M, male, NT, not tested.

b

Week of treatment when PBMC were obtained.